Guidelines for diagnosis and treatment of myocarditis (JCS 2009): Digest version

Circulation Journal

Volumn 75, Issue 3, 2011, Pages 734-743

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR ALPHA; C REACTIVE PROTEIN; CATECHOLAMINE; CORTICOSTEROID; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALLIUM 67; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; NAFAMSTAT MESILATE; PHOSPHODIESTERASE III INHIBITOR; PREDNISOLONE; TECHNETIUM 99M; TROPONIN T; ULINASTATIN;

AORTA BALLOON; ARTICLE; AUTOIMMUNE DISEASE; DISEASE CLASSIFICATION; DRUG MEGADOSE; ELECTROCARDIOGRAM; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRACTICE GUIDELINE; PROGNOSIS; RESUSCITATION; SARCOIDOSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; BIOPSY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MYOCARDITIS;

EID: 79952351661     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-88-0008     Document Type: Article

References (43)

1. Clements GB. Characteristics of viruses inducing cardiac disease. In: Banatvala JE, editor. Viral infections of the heart. London: Edward Arnold, 1993; 1-22.
2. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466-472.
3. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis. Guideline for diagnosing chronic myocarditis. Jpn Circ J 1996; 60: 263-264.
4. Aoyama N, Izumi T, Hiramori K, Isobe M, Kawana M, Hiroe M, et al. Japanese Investigators of Fulminant Myocarditis: National survey of fulminant myocarditis in Japan: Therapeutic guidelines and longterm prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002; 66: 133-144.
5. Kawamura K, Kitaura Y, Deguchi H, Kodaka M. The Etiology Unit of the MHW Specific Disease Idiopathic Cardiomyopathy Study Group: Nationwide questionnaire survey on viral or idiopathic cardiomyopathy, third report-Results of survey in 1982 and 1985. In: MHW Specific Disease Idiopathic Cardiomyopathy Study Group Report in 1985. 1986; 23-36 (in Japanese).
6. Lauer B, Niederau C, Kühl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-1359.
7. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997; 95: 163-168.
8. Hiramitsu S, Morimoto S, Kato S, Uemura A, Kubo N, Kimura K, et al. Transient ventricular wall thickening in acute myocarditis: A serial echocardiographic and histological study. Jpn Circ J 2001; 65: 863-866.
9. Liu PP, Yan AT. Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: Prospects for detecting myocardial inflammation. J Am Coll Cardiol 2005; 45: 1823-1825.
10. Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822.
11. Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG, et al. Differentiating acute myocardial infarction from myocarditis: Diagnostic value of early-and delayed perfusion cardiac MR imaging. Radiology 2005; 237: 75-82.
12. O'Connell JB, Henkin RE, Robinson JA, Subramanian R, Scanlon PJ, Gunnar RM. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984; 70: 58-62.
13. Morguet AJ, Munz DL, Kreuzer H, Emrich D. Scintigraphic detection of inflammatory heart disease. Eur J Nucl Med 1994; 21: 666-674.
14. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 1999; 99: 1091-1100.
15. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007; 50: 1914-1931.
16. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005; 111: 887-893.
17. Kawamura K, Kitaura Y, Deguchi H. The Etiology Unit of the MHW Specific Disease Idiopathic Cardiomyopathy Study Group: Guidelines for the diagnosis of acute cardiomyopathy. In: MHW Specific Disease Idiopathic Cardiomyopathy Study Group Report in 1986. 1987; 13-14 (in Japanese).
18. Okada R, Sekiguchi M, Kawamura K, Kawai C, Toshima H, Nimura Y. Criteria for pathological diagnosis of viral or idiopathic cardiomyopathy with myocardial biopsy: Pathology unit collaborative study. In: MHW Specific Disease Idiopathic Cardiomyopathy Study Group Report in 1988. 1989; 181-182 (in Japanese).
19. Kodama M, Okura Y, Hirono S, Hanawa H, Ogawa Y, Itoh M, et al. A new scoring system to predict the efficacy of steroid therapy for patients with active myocarditis: A retrospective study. Jpn Circ J 1998; 62: 715-720.
20. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, et al. Intravenous immunoglobulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997; 95: 2476-2478.
21. Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and longterm mortality of the clinical subtypes of myocarditis. Jpn Circ J 2001; 65: 961-964.
22. Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, Lai LP, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: What mechanical support should be considered first? J Heart Lung Transplant 2005; 24: 81-87.
23. Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, et al. Risk factors for patients developing a fulminant course with acute myocarditis. Circ J 2004; 68: 734-739.
24. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695.
25. Shirani J, Freant LJ, Roberts WC. Grossand semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy. Am J Cardiol 1993; 72: 952-957.
26. Okura Y, Dec WG, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003; 41: 322-329.
27. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis. natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860-1866.
28. Mori N, Morimoto S, Hiramitsu S, Uemura A, Kubo N, Ohtsuki M, et al. Clinical pictures of 35 cases with eosinophilic myocarditis. Circ J 2004; 68(Suppl I): 244 (abstract).
29. Morimoto S, Kubo N, Hiramitsu S, Uemura A, Ohtsuki M, Kato S, et al. Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis. Heart Vessels 2003; 18: 193-196.
30. Watanabe N, Nakagawa S, Fukunaga T, Fukuoka S, Hatakeyama K, Hayashi T. Acute necrotizing eosinophilic myocarditis successfully treated by high dose methylprednisolone. Jpn Circ J 2001; 65: 923-926.
31. Burgstaler EA, Cooper LT, Winters JL. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: A comparison of immunoglobulin reduction using two different techniques. J Clin Apher 2007; 22: 224-232.
32. Wistø E, Palacios G, Cinek O, Stene LC, Grinde B, Janowitz D, et al. High prevalence of human enterovirus A infections in natural circulation of human enteroviruses. J Clin Microbiol 2006; 44: 4095-4100.
33. Guarner J, Paddock CD, Shien WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis 2006; 43: 132-140.
34. Nieminen MS, Heikkilä J, Karjalainen J. Echocardiography in acute infectious myocarditis: Relation to clinical and electrocardiographic findings. Am J Cardiol 1984; 53: 1331-1337.
35. Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2002-2003 Joint Working Groups Report). Guidelines for Diagnosis and Treatment of Myocarditis. Circ J 2004; 68(Suppl IV): 1231-1263 (in Japanese).
36. Bendig JW, Franklin OM, Hebden AK, Backhouse PJ, Clewley JP, Goldman AP, et al. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol 2003; 70: 606-609.
37. Saji T, Nakazawa M, Harada K, Matsuura H. Diagnosis and treatment of acute myocarditis in neonatal period: Nationwide surveillance. Pediatric Cardiology and Cardiac Surgery 2004; 20: 12-15 (in Japanese).
38. Abzug MJ. Perinatal enterovirus infections. In: Rotbart HA, editor. Human enterovirus infections. Washington DC: ASM Press; 1995: 221-238.
39. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
40. The Japan Society of Sarcoidosis and other Granulomatous Disorders, the Japanese Respiratory Society, the Japanese College of Cardiology, the Japanese Ophthalmological Society, the MHLW Science Research-Diffuse Pulmonary Disease Study Group of the Specific Disease Treatment Program, editors. Outline of the treatment of sarcoidosis in 2003. Available at http://jssog.com/ (accessed in March 2009) (in Japanese).
41. Tamura N. Pericarditis in collagen disease and systemic vasculitis. In: Yazaki Y, editor. Cardiovascular syndromes II. Osaka: Nippon Rinsho Sha; 2007; 368-371 (in Japanese).
42. Hashimoto K. Study of criteria for diagnosis and guidelines for treatment of Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and hypersensitivity syndrome. In: MHLW Science Special Research Program Final Report (2005) (In Japanese).
43. The Ministry of Health, Labour and Welfare. Treatment manual for serious adverse drug reactions-Drug sensitivity syndrome. June 2007 (In Japanese).